Lymphokine gene therapy for cancer
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 11 (6), 196-200
- https://doi.org/10.1016/0167-5699(90)90081-j
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The cytokine networkImmunology Today, 1989
- Adoptive immunotherapy of cancer with macrophages: Current approaches and further prospectsEuropean Journal of Cancer and Clinical Oncology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells.The Journal of Experimental Medicine, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia.Journal of Clinical Investigation, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Minute virus of mice inhibits cell transformation by simian virus 40Nature, 1982
- Lack of Oncogenic Effect of the H-Viruses for HamstersNature, 1967
- Susceptibility of the Rhesus Monkey (Macaca mulatta) to H-1 VirusNature, 1966